日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Maximizing Single-Feature Separability for Improving Transfer Learning in Motor Imagery EEG Decoding

最大化单特征可分离性以改进运动想象脑电解码中的迁移学习

期刊:Brain Sciences
影响因子:2.8
doi:10.3390/brainsci16020230
Xu, Zefeng; Yu, Zhuliang
神经科学
发表日期：2026
文献求助 收藏

Entropy-Based Dual-Teacher Distillation for Efficient Motor Imagery EEG Classification

基于熵的双教师蒸馏法实现高效的运动想象脑电图分类

期刊:Entropy
影响因子:2
doi:10.3390/e28030310
Xu, Zefeng; Yu, Zhuliang
神经科学
发表日期：2026
文献求助 收藏

Autoimmune myelofibrosis with a TLR8 gain-of-function defect

伴有TLR8功能获得性缺陷的自身免疫性骨髓纤维化

期刊:Leukemia Research Reports
影响因子:0.9
doi:10.1016/j.lrr.2026.100587
Qu, Shiqiang; Zhang, Peihong; Xu, Zefeng; Qin, Tiejun; Li, Bing; Xiao, Zhijian
免疫/内分泌
发表日期：2026
文献求助 收藏

Ferroelectric-based Pockels photonic memory

基于铁电体的Pockels光子存储器

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-63850-z
Xu, Zefeng; Chen, Chun-Kuei; Lin, Hong-Lin; Sivan, Maheswari; Zamburg, Evgeny; Lee, James Yong-Meng; Venkatesan, Suresh; Danner, Aaron; Thean, Aaron Voon-Yew
发表日期：2025
文献求助 收藏

A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasms.

无效红细胞生成与骨髓增生异常综合征/肿瘤信号通路失调的相关性

期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00664-1
Wu Junying, Liu Jinqin, Chen Jia, Yang Lin, Li Fuhui, Qin Tiejun, Xu Zefeng, Liu Jing, Zhou Jiaxi, Shi Lihong, Li Bing, Xiao Zhijian
信号转导
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Molecular characteristics and clinical implications of TP53 mutations in therapy-related myelodysplastic syndromes

TP53突变在治疗相关性骨髓增生异常综合征中的分子特征和临床意义

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01276-y
Bao, Zefei; Li, Bing; Qin, Tiejun; Xu, Zefeng; Qu, Shiqiang; Jia, Yujiao; Li, Chengwen; Pan, Lijuan; Gao, Qingyan; Jiao, Meng; Wang, Huijun; Sun, Qi; Xiao, Zhijian
P53
发表日期：2025
文献求助 收藏

Impact of ASXL1 Gene Alterations on Myelodysplastic Syndrome With Isolated 20q Deletion

ASXL1基因改变对伴有孤立性20q缺失的骨髓增生异常综合征的影响

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70747
Chang, Yanan; Liu, Linlin; Cui, Chenghua; He, Jiange; Li, Chengwen; Jia, Yujiao; Zhang, Ruixue; Wu, Wanyun; Zhou, Ji; Xiao, Jigang; Xu, Zefeng; Qin, Tiejun; Sun, Qi; Wang, Huijun; Xiao, Zhijian
ASXL1
发表日期：2025
文献求助 收藏

Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis

预测伴有SF3B1突变和血小板增多症的骨髓增生异常/骨髓增殖性肿瘤患者的生存期

期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-024-02262-2
Li, Fuhui; Qin, Tiejun; Li, Bing; Qu, Shiqiang; Pan, Lijuan; Zhang, Peihong; Sun, Qi; Cai, Wenyu; Gao, Qingyan; Jiao, Meng; Li, Junjie; Ai, Xiaofei; Ma, Jiao; Gale, Robert Peter; Xu, Zefeng; Xiao, Zhijian
SF3B1
血小板
肿瘤免疫
肿瘤
发表日期：2024
文献求助 收藏

Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression

原发性骨髓纤维化不同阶段的非驱动突变图谱表明，ASXL1突变在疾病进展中起着关键作用。

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00829-3
Yan, Xin; Xu, Zefeng; Zhang, Peihong; Sun, Qi; Jia, Yujiao; Qin, Tiejun; Qu, Shiqiang; Pan, Lijuan; Li, Zhanqi; Liu, Jinqin; Song, Zhen; Gao, Qingyan; Jiao, Meng; Gong, Jingye; Wang, Huijun; Li, Bing; Xiao, Zhijian
ASXL1
发表日期：2023
文献求助 收藏

Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy

一例隐匿性TNIP1::PDGFRB重排伴骨髓增生异常综合征的病例，经低剂量伊马替尼联合地西他滨治疗后，血液学和细胞遗传学均达到缓解。

期刊:Leukemia Research Reports
影响因子:0.9
doi:10.1016/j.lrr.2023.100367
Qu, Shiqiang; Yan, Yiru; Li, Chengwen; Xu, Zefeng; Cai, Wenyu; Qin, Tiejun; Zhang, Peihong; Jia, Yujiao; Pan, Lijuan; Gao, Qingyan; Li, Bing; Liu, Jinqin; Jiao, Meng; Xiao, Zhijian
PDGFRB
细胞生物学
发表日期：2023
文献求助 收藏